Abstract
The increased importance of privately sponsored biotechnology research has led to mergers, strategic alliances, vertical coordination, technology licensing, and other changes among firms within the agricultural sector. The industry is in the midst of sweeping changes, and research and development has become a central driver. Competition concerns are emerging that had not existed in the past and will likely bring increased antitrust scrutiny. This article outlines the economic principles that underlie efficient competition, especially those in high-technology industries. It then uses these principles to analyze the new strategic practices that may trigger increased intervention under competition policy. In particular, the article considers the effects of mergers, research joint ventures, technology licensing, and product tying and bundling.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
